Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Allal Boutajangout

Allal Boutajangout

Research Associate Professor
Department of Neurology, Neuroscience and Physiology
USA

Biography

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU

Research Interest

Dr. Boutajangout is a Research Associate Professor of Neurology and Neuroscience & Physiology and Psychiatry. He serves as the chief of the Neurodegeneration and Drug Discovery Program within the Center for Cognitive Neurology at NYU. His research focuses on a new derivative peptide of Amyloid beta for use as immunotherapy or vaccine that trains the immune system to recognize and remove amyloid-beta in the brain as well as on a novel therapy targeting one of the major hallmarks of Alzheimer’s disease, Neurofibrillary tangles. He was an integral part of the group at NYU who developed the first vaccines (active and passive immunization) targeting tau pathology in animal models of AD. More recently, he explores the possible therapeutic potential effect of the Stem Cell in AD mouse models. He is now focusing on the development of a new therapy and immunotherapy targeting Alzheimer’s disease and other related disorders such as prion, stroke and brain Injury.